<DOC>
	<DOC>NCT01320332</DOC>
	<brief_summary>The purpose of this study is to determine the pharmacokinetics (PK) and to assess safety and tolerability of a single dose of ASP3291 in subjects with ulcerative colitis.</brief_summary>
	<brief_title>A Study of a Single Dose of ASP3291 in Subjects With Ulcerative Colitis</brief_title>
	<detailed_description>After an 11-day screening period, subjects check into a clinic, are dosed on Day 1 and stay in the clinic for 4 days to monitor pharmacokinetic and safety parameters.</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis, Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Subject has a previously documented diagnosis of ulcerative colitis (UC) with endoscopy and histology consistent with diagnosis If female, the subject is at least 2 years postmenopausal or is surgically sterile per documentation provided by a third party medical professional or the subject agrees to use 2 highly effective methods of birth control during the study and is not pregnant or lactating Subject is willing and able to comply with the study requirements Subject has a body mass index (BMI) of &lt;32 kg/m2 Subject has ulcerative colitis requiring treatment with 5aminosalicylic acid (5ASA) Subject has undergone previous resective colonic surgery Subject has previously diagnosed Crohn's Disease based on medical history Subject has an extension of disease limited to ulcerative proctitis Subject has active peptic ulcer disease based on medical history Subject is currently being treated with any prescription medication except the following: A stable dose of 5aminosalicylic acid (5ASA) for at least 2 weeks, oral contraceptives or hormone replacement therapy (HRT) Subject has a history of human immunodeficiency virus (HIV) Subject has a history of severe allergic or anaphylactic reactions Subject has a history of drug or alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Ulcerative colitis</keyword>
	<keyword>ASP3291</keyword>
</DOC>